05/01/2025
5:31 PM | Fairmount Funds Management LLC (Filed by)
Aerovate Therapeutics (Subject)
| Form SCHEDULE 13D | |
05/01/2025
4:44 PM | Aerovate Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:51 PM | Aerovate Therapeutics (Issuer)
Lavelle Erin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:58 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Aerovate Therapeutics (Issuer)
Kiselak Tomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
5:00 PM | DOBMEIER ERIC (Reporting)
Aerovate Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:07 PM | CAIN CHRISTOPHER W. (Reporting)
Aerovate Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:10 PM | Aerovate Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:15 PM | Aerovate Therapeutics (Issuer)
Lavelle Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:16 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Aerovate Therapeutics (Issuer)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
4:21 PM | Frohlich Tom (Reporting)
Aerovate Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:22 PM | Aerovate Therapeutics (Issuer)
Quick Jonathan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for AVTE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/01/2025
4:27 PM | Aerovate Therapeutics (Issuer)
King Andrew James (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:30 PM | Aerovate Therapeutics (Issuer)
Kocinsky Hetal (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:32 PM | Balta Elizabeth (Reporting)
Aerovate Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:39 PM | DOBMEIER ERIC (Reporting)
Aerovate Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:41 PM | CAIN CHRISTOPHER W. (Reporting)
Aerovate Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
3:22 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
3:30 PM | Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2025
3:37 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
7:07 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2025
3:20 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
04/09/2025
6:00 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2025
6:01 AM | Aerovate Therapeutics (Subject)
| Form 425 | |
04/07/2025
7:39 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2025
7:42 AM | Aerovate Therapeutics (Subject)
| Form 425 | |
04/07/2025
7:46 AM | Aerovate Therapeutics (Subject)
| Form 425 | |
03/27/2025
6:30 AM | Aerovate Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2025
3:54 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
03/25/2025
11:15 PM | Aerovate Therapeutics (Filer)
| Form EFFECT | |
03/25/2025
3:25 PM | Aerovate Therapeutics (Filer)
| Form 424B3 | |
03/24/2025
9:45 AM | Aerovate Therapeutics (Filer)
| Form S-4/A | |
03/14/2025
4:16 PM | Aerovate Therapeutics (Filer)
| Form S-4/A | |
03/03/2025
3:45 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
02/24/2025
8:57 AM | Aerovate Therapeutics (Filer)
| Form S-4/A | |
01/24/2025
3:17 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
01/22/2025
7:45 AM | Aerovate Therapeutics (Filer)
| Form S-4/A | |
01/13/2025
4:24 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
12/03/2024
5:27 AM | Aerovate Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
11/18/2024
4:29 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
3:55 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
3:55 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
The Man I Turn to In Times Like This (Ad) A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.”
Tilson just released a new prediction that runs counter to what mainstream finance is telling you. Market chaos? Hear Tilson’s take now |
10/31/2024
3:57 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
3:57 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
8:27 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
8:29 AM | Aerovate Therapeutics (Subject)
| Form 425 | |
10/17/2024
3:59 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
4:04 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:31 PM | Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
7:00 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
5:00 PM | Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
06/20/2024
4:56 PM | Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:35 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:44 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
4:00 PM | Aerovate Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/07/2024
7:29 PM | Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dorval Allison (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Iwicki Mark T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Katabi Maha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Resnick Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Santel Donald J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
6:10 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
6:10 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:57 PM | Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
3:39 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
4:59 PM | Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Buy AVTE Stock Free AVTE Stock Alerts